↓ Skip to main content

Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)

Overview of attention for article published in BMC Cancer, December 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
85 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
Published in
BMC Cancer, December 2020
DOI 10.1186/s12885-020-07690-8
Pubmed ID
Authors

Wolfgang M. Brueckl, Joachim H. Ficker, Gloria Zeitler

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Other 15 14%
Student > Bachelor 14 13%
Researcher 11 10%
Student > Doctoral Student 9 8%
Student > Ph. D. Student 9 8%
Other 15 14%
Unknown 38 34%
Readers by discipline Count As %
Medicine and Dentistry 27 24%
Biochemistry, Genetics and Molecular Biology 19 17%
Immunology and Microbiology 7 6%
Nursing and Health Professions 4 4%
Engineering 3 3%
Other 9 8%
Unknown 42 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2022.
All research outputs
#14,931,785
of 23,881,329 outputs
Outputs from BMC Cancer
#3,479
of 8,483 outputs
Outputs of similar age
#275,395
of 512,981 outputs
Outputs of similar age from BMC Cancer
#39
of 124 outputs
Altmetric has tracked 23,881,329 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,483 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 512,981 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.